As the United States aims to increase early diagnosis and treatment of people with HIV, a greater focus has been placed on determining the accuracy of HIV tests in real-world settings—not only to ...

Elena Vaughan received funding from the Irish Research Council for her research on HIV stigma in Irish healthcare settings. Speaking at the 16th International Aids Conference in 2006, the then ...

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up ...

A rash may occur after you contract HIV. It commonly appears on the face and chest but can also appear in other places. Medications used to treat HIV as well as certain infections may also cause ...

LONDON, Dec 17 (Reuters) - A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday.

Postexposure prophylaxis (PEP) is a type of medication that can help prevent HIV from developing in people who may have experienced exposure to the virus. A person can get PEP after speaking with ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as claimed in social media posts. Apart from rare and dangerous stem cell ...

After about 2 to 4 weeks of exposure to HIV, a person may have rashes and flu-like symptoms. After this, there may be no symptoms for several years until the effects of immune system damage appear.